UBS (Lux) Equity SICAV - Healthy Living (USD) U-X-acc

Reference Data

ISIN LU2591956839
Valor Number 125205293
Bloomberg Global ID UBHELUX LX
Fund Name UBS (Lux) Equity SICAV - Healthy Living (USD) U-X-acc
Fund Provider UBS Asset Management Switzerland AG, Zurich 8098 Zürich, Schweiz
E-Mail: ubs-am-wholesale-switzerland@ubs.com
Web: www.ubs.com/fonds
Fund Provider UBS Asset Management Switzerland AG, Zurich
Representative in Switzerland UBS Fund Management (Switzerland) AG
Basel
Phone: +41 61 288 49 10
Distributor(s)
Asset Class Equities
EFC Category Equity Health Care
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** UBS Asset Management categorises this sub-fund as a Sustainability Focus Fund. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). This actively managed sub-fund invests at least 80% of its assets in equities and other equity interests of companies in developed and emerging markets worldwide that have exposure to sustainable themes which the Portfolio Manager considers to be critical to the trend of healthy living and disease prevention. Those include but are not limited to, healthy lifestyle, healthy nutrition, consumerization of health, disease prevention, mental well-being and longevity. Lifespan increased significantly over the past century, yet the time spent in a healthy state (i.e. health span) still lags behind.
Peculiarities

Fund Prices

Current Price * 10,417.62 USD 17.04.2025
Previous Price * 10,334.26 USD 16.04.2025
52 Week High * 12,097.14 USD 30.01.2025
52 Week Low * 9,749.27 USD 08.04.2025
NAV * 10,417.62 USD 17.04.2025
Issue Price * 10,417.62 USD 17.04.2025
Redemption Price * 10,417.62 USD 17.04.2025
Closing Price *
Indicative Minimum Price
Fund Assets *** 4,976,015
Unit/Share Assets *** 4,662,062
Trading Information SIX

Performance

YTD Performance -6.71% 31.12.2024
16.04.2025
YTD Performance (in CHF) -16.43% 31.12.2024
16.04.2025
1 month -5.87% 17.03.2025
16.04.2025
3 months -7.37% 16.01.2025
16.04.2025
6 months -11.45% 16.10.2024
16.04.2025
1 year +1.87% 16.04.2024
16.04.2025
2 years +3.76% 06.07.2023
16.04.2025
3 years - -
5 years - -

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Apple Inc 8.09%
Eli Lilly and Co 5.89%
Danone SA 5.41%
Haleon PLC 5.02%
Koninklijke Philips NV 5.01%
Guardant Health Inc 4.55%
Alcon Inc 3.67%
Novo Nordisk AS Class B 3.53%
DexCom Inc 2.84%
Novonesis (Novozymes) B Class B 2.74%
Last data update 28.02.2025

Cost / Risk

TER 0.04%
TER date 31.05.2024
Performance Fee *** 0.00%
PTR
Max. Management Fee *** 0.00%
Ongoing Charges *** 0.05%
SRRI ***
SRRI date *** 31.03.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)